PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activityLarissa S. Carnevalli, Simon T. Barry|Journal for ImmunoTherapy of Cancer|2018Cited by 87
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug responseDimitra Georgopoulou, Shelley Harris, Alistair Martin et al.|Nature Communications|2021Cited by 59